|
|
|
Insider
Information: |
Moran Sean F. |
Relationship: |
|
City: |
Columbia |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
143,605 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,190,535 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
143,605 |
|
|
Total
Value |
$2,190,535 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
1,046.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Celsion Corp |
CLSN |
Chief Financial Officer |
2009-03-17 |
35,000 |
2009-01-19 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Invivo Therapeutics Holdings Cor... |
NVIV |
Acting Chief Financial... |
2013-09-03 |
60,000 |
2013-08-29 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Corbus Pharmaceuticals Holdings,... |
CRBP |
|
2024-06-18 |
48,605 |
2014-11-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-06-14 |
4 |
AS |
$49.87 |
$466,569 |
D/D |
(9,355) |
48,605 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-06-17 |
4 |
AS |
$46.77 |
$314,789 |
D/D |
(6,730) |
48,605 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2016-08-17 |
4 |
B |
$3.19 |
$267,832 |
D/D |
83,960 |
216,410 |
2.74 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2016-08-18 |
4 |
B |
$3.48 |
$226,200 |
D/D |
65,000 |
281,410 |
2.74 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2016-09-08 |
4 |
B |
$5.12 |
$157,696 |
D/D |
30,800 |
330,110 |
2.74 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2020-12-21 |
4 |
AS |
$1.75 |
$153,125 |
D/D |
(87,500) |
349,610 |
0 |
% |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2020-12-21 |
4 |
OE |
$1.40 |
$122,500 |
D/D |
87,500 |
437,110 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-06-17 |
4 |
OE |
$14.10 |
$94,893 |
D/D |
6,730 |
55,335 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-06-18 |
4 |
AS |
$42.12 |
$82,479 |
D/D |
(1,958) |
48,605 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-06-14 |
4 |
OE |
$4.26 |
$80,187 |
D/D |
9,355 |
56,393 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2020-12-18 |
4 |
AS |
$1.40 |
$75,054 |
D/D |
(53,610) |
349,610 |
0 |
% |
|
CLSN |
Celsion Corp |
Chief Financial Officer |
|
2008-12-08 |
4 |
A |
$3.00 |
$75,000 |
D/D |
25,000 |
25,000 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2016-05-18 |
4 |
B |
$2.39 |
$71,700 |
D/D |
30,000 |
105,250 |
2.74 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2016-08-26 |
4 |
B |
$3.92 |
$70,168 |
D/D |
17,900 |
299,310 |
2.74 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2016-05-19 |
4 |
B |
$2.37 |
$64,583 |
D/D |
27,250 |
132,450 |
2.74 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2014-12-18 |
4 |
B |
$3.36 |
$63,168 |
D/D |
18,800 |
31,350 |
2.74 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-06-18 |
4 |
OE |
$30.00 |
$58,740 |
D/D |
1,958 |
50,563 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2020-12-18 |
4 |
OE |
$1.00 |
$53,610 |
D/D |
53,610 |
403,220 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2024-04-10 |
4 |
OE |
$30.00 |
$53,610 |
D/D |
1,787 |
48,605 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2020-12-16 |
4 |
AS |
$1.32 |
$48,628 |
D/D |
(36,923) |
349,610 |
0 |
% |
|
NVIV |
Invivo Therapeutics Holdi... |
Acting Chief Financial Officer |
|
2013-08-29 |
4/A |
B |
$1.23 |
$34,440 |
D/D |
28,000 |
28,000 |
2.74 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
Acting Chief Financial Officer |
|
2013-08-29 |
4 |
S |
$1.23 |
$34,440 |
D/D |
(28,000) |
28,000 |
0 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2018-05-15 |
4 |
B |
$5.77 |
$23,080 |
D/D |
4,000 |
348,010 |
2.74 |
- |
|
CRBP |
Corbus Pharmaceuticals Ho... |
Chief Financial Officer |
|
2018-03-14 |
4 |
B |
$6.60 |
$20,460 |
D/D |
3,100 |
344,010 |
2.74 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
Acting Chief Financial Officer |
|
2013-09-03 |
4 |
B |
$1.02 |
$20,400 |
D/D |
20,000 |
60,000 |
2.74 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|